MUMBAI, India, June 19 -- Intellectual Property India has published a patent application (202617054736 A) filed by St Pharm Co. , Ltd. on April 29, 2026, for Crystalline Form Of Triazolopyrimidinone Derivative.
Inventors include Kim, Uk-Il; and Bang, Hyung Tae.
The application for the patent was published on June 05, 2026, under issue no. 23/2026.
Abstract: The present invention relates to a polymorphism of a triazolopyrimidinone derivative exhibiting tankyrase inhibitory activity, and a preparation method therefor. The novel polymorphism of the present invention exhibits excellent non-hygroscopicity and stability, and exhibits excellent solubility and bioavailability, and thus is suitable as a raw material for pharmaceutical preparations.
Disclaimer: Curated by HT Syndication.
